Sound Shore Management INC Increased Merck & Co. INC (MRK) Stake by $57.39 Million; Shares Rose

June 27, 2018 - By Mark Williams

Merck & Co., Inc. (NYSE:MRK) Corporate LogoBig Money Sentiment increased to 1 in Q1 2018. It has change of 0.06, from 2017Q4’s 0.94. The ratio improved due to MRK positioning: 72 sold and 603 reduced. 114 funds amassed positions and 561 increased positions. Investors holded 1.93 billion in 2017Q4 but now own 1.91 billion shares or 1.08% less. Asset Management One Communication holds 0.55% or 4.50 million shs. Eagleclaw Managment Limited Com owns 27,050 shs. Inv Mgmt Of Virginia Ltd Limited Liability Company owns 56,141 shs. Jefferies Grp Incorporated Ltd Liability holds 91,851 shs. Donaldson Capital Mgmt Ltd Limited Liability Company has 0.17% invested in Merck & Co., Inc. (NYSE:MRK). Moreover, Cibc Ww has 0.97% invested in Merck & Co., Inc. (NYSE:MRK) for 1.68M shs. Wheatland Advsr Inc reported 10,396 shs or 0.47% of all its holdings. Redmond Asset Management Ltd Co has invested 0.12% in Merck & Co., Inc. (NYSE:MRK). Cubic Asset Mgmt Ltd Com holds 0.24% or 15,812 shs in its capital. Schmidt P J Investment Management reported 61,200 shs. Beech Hill Advsrs holds 2.8% or 97,712 shs. 47,659 were accumulated by Horizon Kinetics Ltd. Bsw Wealth Prtnrs reported 5,311 shs. Clarivest Asset Mngmt Limited Liability holds 0.01% or 5,389 shs. Baystate Wealth Management Limited holds 5,110 shs.

In 2018Q1 SEC form is reported Sound Shore Management Inc’s holdings in Merck & Co. Inc. (MRK) which was upped by 29.22%. The company’s stock popped up 5.40% while Sound Shore Management Inc bought 1.06M shares. The institutional investor is holding 4.70M shares, compared to the 3.64 million from the previous quarter. And the announced value of the health care company is $256.01 million for the 2018Q1. Merck & Co. Inc. has $163.33 billion MC. The stock decreased 0.61% or $0.37 during the last trading session, touching $60.71.Currently Merck & Co., Inc. is downtrending after 9.15% change in last June 27, 2017. MRK has also 10.32 million shares volume. MRK underperformed by 21.72% the S&P 500.

Sound Shore Management Inc reduced its stake in Pentair Plc (NYSE:PNR) by 281,506 shares to 2.24M shares, valued at $152.58 million in 2018Q1, according to the filing. It operates about $6.15B and $6.18B US Long portfolio. For a total of 745,552 shares it reduced its holding in Thermo Fisher Scientific (NYSE:TMO) by 231,407 shares in the quarter, and has cut its stake in Delta Air Lines Inc (NYSE:DAL).

For more Merck & Co., Inc. (NYSE:MRK) news announced briefly go to:,,, or The titles are as follows: “Software startup Celonis clinches $50M in venture capital” announced on June 26, 2018, “Merck to Hold Second-Quarter 2018 Sales and Earnings Conference Call on July 27” on June 27, 2018, “3 Best Big Pharma Stocks of 2018 So Far” with a publish date: June 26, 2018, “Wall Street Breakfast: Oil Back Above $70” and the last “The Best Dividend-Paying Biotech Stocks For Your Portfolio” with publication date: June 25, 2018.

Merck & Co., Inc. (NYSE:MRK) Ratings Coverage

Total analysts of 12 have positions in Merck \u0026 Co (NYSE:MRK) as follows: 10 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 83%. The firm has $7300 highest while $5500 is the lowest price target. The average target $66.89 is 10.18% above the last ($60.71) price. Since January 16, 2018 according to StockzIntelligence Inc Merck \u0026 Co has 19 analyst reports. On Friday, March 23 the firm earned “Hold” rating by Jefferies. In Monday, February 26 report Jefferies maintained it with “Hold” rating and $56.0 target. On Tuesday, January 16 the firm has “Hold” rating given by Jefferies. In Monday, March 12 report Leerink Swann upgraded it to “Buy” rating and $66.0 target. In Friday, April 20 report Cowen & Co maintained it with “Hold” rating and $6700 target. On Wednesday, February 14 the firm earned “Outperform” rating by BMO Capital Markets. The company rating was maintained by Guggenheim on Tuesday, April 17. On Tuesday, April 17 Bank of America maintained Merck & Co., Inc. (NYSE:MRK) with “Buy” rating. On Monday, April 23 Goldman Sachs upgraded the shares of MRK in report to “Buy” rating. On Monday, February 5 the stock has “Outperform” rating by Credit Suisse.

Merck & Co., Inc. (NYSE:MRK) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.